TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$52.03M2018: -$59.16M2019: -$51.44M2020: $34.88M2021: -$60.38M2022: -$31.63M2023: -$51.16M2024: -$23.67M2025: -$73.94M-$73.94M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$73.94M-212.3%
2024-$23.67M+53.7%
2023-$51.16M-61.7%
2022-$31.63M+47.6%
2021-$60.38M-273.1%
2020$34.88M+167.8%
2019-$51.44M+13.1%
2018-$59.16M-13.7%
2017-$52.03M—